Fortress Biotech, Inc. (FBIO) › RevenueFortress Biotech, Inc. (FBIO) — RevenueAnnual figures by fiscal year, from SEC filings.2015: $863.0K2016: $16.48M2017: $17.25M2018: $26.88M2019: $36.63M2020: $45.60M2021: $68.79M2022: $75.74M2023: $84.51M2024: $57.67M2025: $63.26M$63.26M2015Revenue (USD)2025Fiscal YearRevenueChange YoY2025$63.26M+9.7%2024$57.67M-31.8%2023$84.51M+11.6%2022$75.74M+10.1%2021$68.79M+50.9%2020$45.60M+24.5%2019$36.63M+36.3%2018$26.88M+55.9%2017$17.25M+4.6%2016$16.48M+1809.6%2015$863.0K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share